Synthesis and screening of a rationally designed combinatorial library of affinity ligands mimicking protein L from Peptostreptococcus magnus

Journal of Molecular Recognition

Volumn 18, Issue 3, 2005, Pages 213-224

  Roque, A Cecília A ^a,b   Taipa, M Ângela ^a   Lowe, Christopher R ^b  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Affinity chromatography; Biomimetic; Immunoglobulins; Ligand; Protein L

Indexed keywords

BACTERIAL PROTEIN; DNA BINDING PROTEIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; L PROTEIN, PEPTOCOCCUS MAGNUS; L-PROTEIN, PEPTOCOCCUS MAGNUS; LIGAND; PEPTIDE LIBRARY;

AFFINITY CHROMATOGRAPHY; AFFINITY LABELING; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG DESIGN; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR MIMICRY; PEPTOSTREPTOCOCCUS; PROTEIN BINDING;

AFFINITY LABELS; BACTERIAL PROTEINS; CHROMATOGRAPHY, AFFINITY; COMBINATORIAL CHEMISTRY TECHNIQUES; DNA-BINDING PROTEINS; DRUG DESIGN; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; LIGANDS; MODELS, MOLECULAR; MOLECULAR MIMICRY; MOLECULAR STRUCTURE; PEPTIDE LIBRARY; PEPTOSTREPTOCOCCUS; PROTEIN BINDING;

FINEGOLDIA MAGNA; PEPTOSTREPTOCOCCUS;

EID: 18944395451     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmr.733     Document Type: Article

References (49)

1. Beckingham JA, Housden NG, Muir NM, Bottomley SP, Gore MG. 2001. Studies on a single immunoglobulin-binding domain of protein L from Peptostreptococcus magnus: the role of tyrosine-53 in the reaction with human IgG. Biochem. J. 353: 395-401.
2. Bennett KL, Smith SV, Truscott RJW, Sheil MM. 1997. Monitoring papain digestion of a monoclonal antibody by electrospray ionization mass spectrometry. Anal. Biochem. 245: 17-27.
3. Blank K, Lindner P, Diefenbach B, Pluckthun A. 2002. Self-immobilizing recombinant antibody fragments for immunoaffinity chromatography: generic, parallel, and scalable protein purification. Protein Expres. Purif. 24: 313-322.
4. Boeijen A, Liskamp RMJ. 1999. Solid-phase synthesis of oligourea peptidomimetics. Eur. J. Org. Chem. 2127-2135.
5. Boschetti E. 2001. The use of thiophilic chromatography for antibody purification: a review. J. Biochem. Bioph. Meth. 49: 361-389.
6. Brekke OH, Sandlie I. 2003. Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat. Rev. Drug Discov. 2: 52-62.
7. Brown BA, Comeau RD, Jones PL, Liberatore FA, Neacy WP, Sands H, Gallagher BM. 1987. Pharmacokinetics of the monoclonal antibody B72.3 and its fragments labeled with either (125)I or (111)In. Cancer Res. 47: 1149-1154.
8. Burton NP, Lowe CR. 1992. Design of novel affinity adsorbents for the purification of trypsin-like proteases. J. Mol. Recognit. 5: 55-68.
9. Cavrois M, de Noronha C, Greene WC. 2002. A sensitive and specific enzyme-assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 20: 1151-1154.
10. Chadd HE, Chamow SM. 2001. Therapeutic antibody expression technology. Curr. Opin. Biotechnol. 12: 188-194.
11. Clezardin P, McGregor JL, Manach M, Boukerche H, Dechavanne M. 1985. One-step procedure for the rapid isolation of mouse monoclonal antibodies and their antigen binding fragments by fast protein liquid chromatography on a mono Q anion-exchange column. J. Chromatogr. 319: 67-77.
12. de Wildt RMT, Mundy CR, Gorick BD, Tomlinson IM. 2000. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat. Biotechnol. 18: 989-994.
13. Derrick JP, Wigley DB. 1992. Crystal structure of a streptococcal protein G domain bound to an Fab fragment. Nature 359: 752-754.
14. Enokizono J, Wikstrom M, Sjobring U, Bjorck L, Forsen S, Arata Y, Kato K, Shimada I. 1997. NMR analysis of the interaction between protein L and Ig light chains. J. Mol. Biol. 270: 8-13.
15. Fassina G, Verdoliva A, Odierna MR, Ruvo M, Cassini G. 1996. Protein a mimetic peptide ligand for affinity purification of antibodies. J. Mol. Recognit. 9: 564-569.
16. Fong RB, Ding Z, Hoffman AS, Stayton PS. 2002. Affinity separation using an Fv antibody fragment-'smart' polymer conjugate. Biotechnol. Bioengng 79: 271-276.
17. Graille M, Stura EA, Corper AL, Sutton BJ, Taussig MJ, Charbonnier JB, Silverman GJ. 2000. Crystal structure of a staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proc. Natl Acad. Sci. USA 97: 5399-5404.
18. Graille M, Stura EA, Housden NG, Beckingham JA, Bottomley SP, Beale D, Taussig MJ, Sutton BJ, Gore MG, Charbonnier JB. 2001. Complex between Peptostreptococcus magnus protein L and a human antibody reveals structural convergence in the interaction modes of Fab binding proteins. Structure 9: 679-687.
19. Graille M, Harrison S, Crump MP, Findlow SC, Housden NG, Muller BH, Battail-Poirot N, Sibai G, Sutton BJ, Taussig MJ, Jolivet-Reynaud C, Gore MG, Stura EA. 2002. Evidence for plasticity and structural mimicry at the immunoglobulin light chain-protein L interface. J. Biol. Chem. 277: 47500-47506.
20. Gulich S, Linhult M, Stahl S, Hober S. 2002. Engineering streptococcal protein G for increased alkaline stability. Protein Engng. 15: 835-842.
21. Housden NG, Harrison S, Roberts SE, Beckingham JA, Graille M, Stura EA, Gore MG. 2003. Immunoglobulin-binding domains: protein L from Peptostreptococcus magnus. Biochem. Soc. Trans. 31: 716-718.
22. Hu SZ, Shivery L, Raubitschek A, Sherman M, Williams LE, Wong JYC, Shively JE, Wu AM. 1996. Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-C(H)S) which exhibits rapid, high-level targeting of xenografts. Cancer Res. 56: 3055-3061.
23. Huse K, Bohme HJ, Scholz GH. 2002. Purification of antibodies by affinity chromatography. J. Biochem. Bioph. Meth. 51: 217-231.
24. Kim DE, Fisher C, Baker D. 2000. A breakdown symmetry in the folding transition state of protein L. J. Mol. Biol. 298: 971-984.
25. Kontermann RE, Wing MG, Winter G. 1997. Complement recruitment using bispecific diabodies. Nat. Biotechnol. 15: 629-631.
26. Kouki T, Inui T, Yamashiro K, Hachiya T, Ochi Y, Kajita Y, Takasu N, Sato Y, Nagata A. 1997. Demonstration of fragments with thyroid stimulating activity from thyroid stimulation blocking antibodies-IgG molecules by papain digestion. Clin. Endocrinol. 47: 693-698.
27. Kruijtzer JAW, Hofmeyer LJF, Heerma W, Versluis C, Liskamp RMJ. 1998. Solid-phase synthesis of peptoids using Fmoc-protected N-substituted glycines: the synthesis of (retro) peptoids of Leu-enkephalin and substance P. Chem. Eur. J. 4: 1570-1580.
28. Laroche-Traineau J, Clofent-Sanchez G, Santarelli X. 2000. Three-step purification of bacterially expressed human single-chain Fv antibodies for clinical applications. J. Chromatogr. B: Biomed. Applic. 737: 107-117.
29. Li RX, Dowd V, Stewart DJ, Burton SJ, Lowe CR. 1998. Design, synthesis, and application of a Protein A mimetic. Nat. Biotechnol. 16: 190-195.
30. Lowe CR, Burton SJ, Burton NP, Alderton WK, Pitts JM, Thomas JA. 1992. Designer dyes - biomimetic ligands for the purification of pharmaceutical proteins by affinity-chromatography. Trends Biotechnol. 10: 442-448.
31. Lowe CR, Lowe AR, Gupta G. 2001. New developments in affinity chromatography with potential application in the production of biopharmaceuticals. J. Biochem. Bioph. Meth. 49: 561-574.
32. Murray A, Smith RG, Brady K, Williams S, Badley RA, Price MR. 2001. Generation and refinement of peptide mimetic ligands for paratope-specific purification of monoclonal antibodies. Anal. Biochem. 296: 9-17.
33. Nilson BHK, Solomon A, Bjorck L, Akerstrom B. 1992. Protein-L from Peptostreptococcus-magnus binds to the kappa-light chain variable domain. J. Biol. Chem. 267: 2234-2239.
34. Nilson BHK, Logdberg L, Kastern W, Bjorck L, Akerstrom B. 1993. Purification of antibodies using protein-L-binding framework structures in the light-chain variable domain. J. Immunol. Meth. 164: 33-40.
35. Palanisamy UD, Hussain A, Iqbal S, Sproule K, Lowe CR. 1999. Design, synthesis and characterisation of affinity ligands for glycoproteins. J. Mol. Recognit. 12: 57-66.
36. Palanisamy UD, Winzor DJ, Lowe CR. 2000. Synthesis and evaluation of affinity adsorbents for glycoproteins: an artificial lectin. J. Chromatogr. B 746: 265-281.
37. Power BE, Hudson PJ. 2000. Synthesis of high avidity antibody fragments (scFv multimers) for cancer imaging. J. Immunol. Meth. 242: 193-204.
38. Reichert JM. 2001. Monoclonal antibodies in the clinic. Nat. Biotechnol. 19: 819-822.
39. Roque ACA, Lowe CR, Taipa MA. 2004a. Antibodies and genetically engineered related molecules: production and purification. Biotechnol. Progr. 20: 639-654.
40. Roque ACA, Taipa MA, Lowe CR. 2004b. A new method for the screening of solid-phase combinatorial libraries for affinity chromatography. J. Mol. Recognit. 17: 262-267.
41. Safar JG, Scott M, Monaghan J, Deering C, Didorenko S, Vergara J, Ball H, Legname G, Leclerc E, Solforosi L, Serban H, Groth D, Burton DR, Prusiner SB, Williamson RA. 2002. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and trangenic mice. Nat. Biotechnol. 20: 1147-1150.
42. Snyder, Sobocinski. 1975. An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines. Anal. Biochem. 64: 284-288.
43. Stura EA, Graille M, Housden NG, Gore MG. 2002. Protein L mutants for the crystallization of antibody fragments. Acta Crystallogr. Sect. D Biol. Crystallogr. 58: 1744-1748.
44. Taipa MA, Kaul R, Mattiasson B, Cabral JMS. 2001. Recovery of a monoclonal antibody from hybridoma culture supernatant by affinity precipitation with Eudragit S-100. Bioseparation 9: 291-298.
45. Teng SF, Sproule K, Hussain A, Lowe CR. 1999. A strategy for the generation of biomimetic ligands for affinity chromatography. Combinatorial synthesis and biological evaluation of an IgG binding ligand. J. Mol. Recognit. 12: 67-75.
46. Teng SF, Sproule K, Husain A, Lowe CR. 2000. Affinity chromatography on immobilized 'biomimetic' ligands synthesis, immobilization and chromatographic assessment of an immunoglobulin G-binding ligand. J. Chromatogr. B. 740: 1-15.
47. van Dijk MA, van de Winkel JGJ. 2001. Human antibodies as next generation therapeutics. Curr. Opin. Chem. Biol. 5: 368-374.
48. Vola R, Lombardi A, Tarditi L, Bjorck L, Mariani M. 1995. Recombinant protein-L and protein-Lg - efficient tools for purification of murine immunoglobulin-G fragments. J. Chromatogr. B: Biomed. Applic. 668: 209-218.
49. Volkel T, Korn T, Bach M, Muller R, Kontermann RE. 2001. Optimized linker sequences for the expression of monomeric and dimeric bispecific single-chain diabodies. Protein Engng. 14: 815-823.